Provided by Tiger Trade Technology Pte. Ltd.

CARSGEN-B

15.750
+0.6204.10%
Volume:1.87M
Turnover:29.40M
Market Cap:9.36B
PE:-88.85
High:15.970
Open:15.440
Low:15.180
Close:15.130
52wk High:28.600
52wk Low:10.870
Shares:594.00M
HK Float Shares:594.00M
Volume Ratio:0.96
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.177
ROE:-11.21%
ROA:-9.61%
PB:10.27
PE(LYR):-88.85
PS:64.03

Loading ...

CARsgen Therapeutics Wins China IND Clearance for Lymphoma Cell Therapy

MT Newswires Live
·
Aug 07

CARSGEN-B (02171) Surges Over 4% as CT1190B Gets IND Nod for R/R LBCL Patients After Second-Line Failure

Stock News
·
Aug 07

CARSGEN-B Receives IND Clearance from Chinese Drug Regulator for Novel Cell Therapy Targeting Lymphoma

Stock News
·
Aug 07

CARsgen Says NMPA Clears IND for Ct1190b in Relapsed/refractory Large B-Cell Lymphoma

Reuters
·
Aug 07

CARsgen Therapeutics - Ct1190b Receives Ind Clearance from Nmpa for Relapsed/Refractory Large B-Cell Lymphoma

THOMSON REUTERS
·
Aug 07

CARsgen Schedules 18 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results

Bulletin Express
·
Aug 06

CARsgen Therapeutics Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 06

CARsgen Therapeutics Receives China IND Clearance for Multiple Myeloma Therapy; Shares Up 3%

MT Newswires Live
·
Aug 04

Carsgen Therapeutics Says Ct0596 Receives IND Clearance from NMPA

Reuters
·
Aug 04

China's Nod Granted to CARSGEN-B's BCMA-Targeting Universal CAR-T for Hard-to-Treat Myeloma

Stock News
·
Aug 04

CARsgen Secures NMPA IND Clearance for Allogeneic BCMA CAR-T Candidate CT0596 in Relapsed/Refractory Multiple Myeloma

Bulletin Express
·
Aug 04

CARsgen Says Ct0596 Wins NMPA IND Clearance for Relapsed/refractory Multiple Myeloma

Reuters
·
Aug 04

CARsgen Therapeutics - Ct0596 Receives Ind Clearance from Nmpa for Relapsed/Refractory Multiple Myeloma

THOMSON REUTERS
·
Aug 04

CARsgen Therapeutics Holdings (SEHK:2171) Gains Clinical Momentum Following Satri Cel Trial Update But Looks Pricey

Simply Wall St.
·
Jul 27

CARSGEN-B Allocates HK$4.98 Million for Share Buyback on July 17

Stock News
·
Jul 17

Carsgen Files HKEX Next-day Disclosure Return, Issues 2,000 New Shares Via Option Exercise

Reuters
·
Jul 17

Movement Alert|CARsgen Therapeutics-B Falls 6.03% in Regular Trading, Biotech Sector Under Broad Selling Pressure

Market Focus
·
Jul 17

CARSGEN-B Shares Surge Over 7% in Session as CT041 Passes Initial Review for 2026 Commercial Health Insurance Innovation Drug Catalog

Deep News
·
Jul 16

Movement Alert|CARsgen Therapeutics-B Rises 5.51% in Regular Trading, Kelimei Post-Surgical Consolidation Therapy Positive Results Accepted for ESMO Poster Presentation

Market Focus
·
Jul 16

Hong Kong Stocks Midday Update: Hang Seng Index Rises 1.46%, Innovation Pharma Soars

Stock News
·
Jul 15